Aubert, Incarnation <br/><br/>
Increased D1 dopamine receptor signaling in levodopa-induced dyskinesia.  [electronic resource] 

 -  Annals of neurology  Jan 2005 
 - 17-26 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0364-5134 
<br/><br/><label>Standard No.: </label>10.1002/ana.20296  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine--pharmacology<br/>2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine--pharmacology<br/>Analysis of Variance<br/>Animals<br/>Antiparkinson Agents--adverse effects<br/>Autoradiography--methods<br/>Behavior, Animal<br/>Blotting, Western--methods<br/>Cyclin-Dependent Kinase 5<br/>Cyclin-Dependent Kinases<br/>Disease Models, Animal<br/>Dopamine Plasma Membrane Transport Proteins<br/>Dopamine and cAMP-Regulated Phosphoprotein 32<br/>Dose-Response Relationship, Drug<br/>Drug Interactions<br/>Dyskinesia, Drug-Induced--etiology<br/>Female<br/>Guanosine 5'-O-(3-Thiotriphosphate)--pharmacokinetics<br/>Immunohistochemistry--methods<br/>In Situ Hybridization--methods<br/>Isotopes--pharmacokinetics<br/>Levodopa--adverse effects<br/>Macaca fascicularis<br/>Membrane Glycoproteins--metabolism<br/>Membrane Transport Proteins--metabolism<br/>Motor Activity--drug effects<br/>Nerve Tissue Proteins--metabolism<br/>Nortropanes--pharmacokinetics<br/>Parkinsonian Disorders--drug therapy<br/>Phosphoproteins--metabolism<br/>Radioligand Assay--methods<br/>Receptors, Dopamine D1--agonists<br/>Receptors, Dopamine D2--genetics<br/>Signal Transduction--drug effects<br/>Substantia Nigra--drug effects<br/>Time Factors<br/>Tyrosine 3-Monooxygenase--metabolism